[Federal Register: April 1, 2005 (Volume 70, Number 62)]
[Notices]
[Page 16920]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01ap05-139]
[[Page 16920]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-217N]
RIN 1117-AA60
Electronic Orders for Controlled Substances: Notice of Meeting
AGENCY: Drug Enforcement Administration (DEA), Justice.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) will hold a public
meeting to provide technical details regarding the use of digital
signatures and public key infrastructure (PKI) technology within DEA's
system for electronic orders for Schedule I and II controlled
substances.
DATES: Wednesday, May 18, 2005, 9 a.m. until 4:30 p.m.
ADDRESSES: Sheraton National Hotel, 900 South Orme Street, Arlington,
VA 22204.
Persons wishing to attend this meeting, space permitting, must
provide attendee information to the Liaison and Policy Section, Office
of Diversion Control, Drug Enforcement Administration, via e-mail to
mandy.a.healy@usdoj.gov, or via facsimile at (202) 353-1079 as
specified below. Persons wishing to attend the meeting must provide
this information to the Liaison and Policy Section no later than
Monday, May 16, 2005.
FOR FURTHER INFORMATION CONTACT: Patricia M. Good, Chief, Liaison and
Policy Section, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, telephone (202) 307-7297.
SUPPLEMENTARY INFORMATION:
Background
In a separate Final Rule published in today's Federal Register, the
Drug Enforcement Administration (DEA) is implementing regulations
regarding the electronic transmission of Schedule I and II controlled
substances orders from purchasers (DEA-registered distributors,
pharmacies and practitioners) to suppliers (DEA-registered
manufacturers and distributors) and the electronic retention of records
pertaining to those orders. DEA is requiring that these electronic
orders be conducted using public key infrastructure (PKI) technology,
including the use of digital certificates issued by the DEA Bridge
Certification Authority.
This meeting is being held to provide information to interested
persons including systems vendors and developers regarding industry's
development of electronic systems which conform to the standards and
regulations DEA is implementing. Persons interested in learning about
the development of such PKI-based systems using DEA's standards may
attend this meeting, so long as space permits.
Background and Supporting Documents
Supporting documents regarding DEA's system to permit the
electronic transmission of Schedule I and II controlled substances
orders and the electronic retention of records pertaining to those
orders, including the Certificate Policy, Certificate Profile,
applications to obtain a digital certificate from the DEA Bridge
Certification Authority, and other pertinent materials may be found
within the Electronic Commerce Initiatives/CSOS section on the
Diversion Control Program Web site: http://www.deadiversion.usdoj.gov/ecomm/index.html, and DEA's E-Commerce Web site: http://www.deaecom.gov.
Meeting Registration
Persons wishing to attend this meeting must provide the following
information to the Liaison and Policy Section, Office of Diversion
Control, Drug Enforcement Administration, via e-mail or facsimile as
listed above:
Name:------------------------------------------------------------------
Title:-----------------------------------------------------------------
Company/Organization:--------------------------------------------------
Address:---------------------------------------------------------------
Telephone:-------------------------------------------------------------
E-mail address:--------------------------------------------------------
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. 05-6505 Filed 3-31-05; 8:45 am]
BILLING CODE 4410-09-P